Cited by 186Reproductive Health and TechnologiesOvarian function and disordersAssisted Reproductive Technology and Twin Pregnancy

Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation

Mitwally, Mohamed F., Biljan, Marinko M., Casper, Robert F.·2005·American Journal of Obstetrics and Gynecology

Abstract

Objective This study was undertaken to report the outcome of pregnancies achieved after ovarian stimulation, including the use of the aromatase inhibitor, letrozole, for ovarian stimulation.Study design A cohort study comparing the outcome of pregnancies achieved after letrozole and other ovarian stimulation treatments with a control group of pregnancies spontaneously conceived without ovarian stimulation.Results In 3 tertiary referral centers, there were 394 pregnancy cycles in 345 infertile couples (63 pregnancies with 2.5 mg of letrozole alone or with gonadotropins, 70 pregnancies with 5.0 mg of letrozole, 113 pregnancies with clomiphene alone or with gonadotropins, 110 pregnancies with gonadotropins alone, and 38 pregnancies achieved without ovarian stimulation). Pregnancies conceived after letrozole treatments were associated with similar miscarriage and ectopic pregnancy rates compared with all other groups. In addition, letrozole use was associated with a significantly lower rate of multiple gestation compared with clomiphene citrate.Conclusion The favorable pregnancy outcome and low multiple gestation rate of aromatase inhibitors for ovarian stimulation is encouraging for the development of these agents as first-line ovulation induction agents.

Integrity signals

Registry

Crossref · 10.1016/j.ajog.2004.08.013

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The multiple pregnancy rate associated with clomiphene citrate is between 10% and 20%.

    “The multiple pregnancy rate associated with CC is between 10% and 20% (14).”

    From A new era in ovulation induction (2006) · cites this paper as [14]

The citation lists haven’t been fetched yet

References 27 · Cited by 186

Authors
Mitwally, M. F., Biljan, M. M., & Casper, R. F.
Affiliations
University of Toronto (CA)
Venue
American Journal of Obstetrics and Gynecology
Publisher
Elsevier BV
Published
2005-02
Volume
192
Issue
2
Pages
381-386
ISSN
0002-9378 (ISSN-L)
OpenAlex
W2065832162
Cited by
186
References
27
Citations by year
2026: 1 · 2022: 5 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 35 · 2016: 3 · 2015: 26 · 2014: 4 · 2013: 8 · 2012: 11
FWCI
17.42
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
Keywords
letrozole, aromatase inhibitors, ovulation induction, pregnancy outcomes, infertility, clomiphene citrate, gonadotropins, miscarriage, ectopic pregnancy, multiple pregnancy, spontaneous conception
MeSH terms
Abortion, Spontaneous, Letrozole, Female, Humans, Nitriles, Ovulation Induction, Pregnancy, Pregnancy Outcome, Pregnancy, Multiple, Triazoles, Cohort Studies, Pregnancy Rate, Aromatase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review